Submitted by reuters8361 in health
The U.S. Centers for Disease Control and Prevention (CDC) on Friday recommended Pfizer's <a href="https://www.reuters.com/markets/companies/PFE.N" target="_blank">(PFE.N)</a> respiratory syncytial virus (RSV) vaccine for women in the middle of the third trime…